Skip to main content

About
Locations
Contact

English
Korean
Chinese, Simplified
Chinese, Traditional

Our Company
Our Culture
Board
Leadership
Awards

News & Resources
Solutions
Expertise
Careers

News & Resources
Solutions
Expertise
Careers
About
Locations
Contact

English
Korean
Chinese, Simplified
Chinese, Traditional

Our Company
Our Culture
Board
Leadership
Awards

English
Korean
Chinese, Simplified
Chinese, Traditional

News & Resources
Solutions
Expertise
Careers
About
Locations
Contact

BACK
Latest News
Latest Reports
Latest Webinars
Upcoming Events
Latest Case Studies
Latest Whitepapers
Latest FAQs
Covid Notices

Novotech Awarded Cell & Gene Therapy CRO Excellence 2023
Novotech Announced as Finalist for Asia Pacific Cell & Gene Therapy CRO Excellence Awards 2023
Novotech Presents Technical Session on Clinical Trial Success Factors at BIOPLUS-INTERPHEX KOREA 2023

View All News

Primary Biliary Cholangitis – Global Clinical Trial Landscape (2023)
Nasopharyngeal Carcinoma: Global Clinical Trial Landscape
Gallbladder Cancer: Global Clinical Trial Landscape

View All Reports

Clinical trials in China: unlocking the potential of advanced therapies
Endpoints at BIO 2023: Forging new biotech ties with China
Endpoints at ASCO23: How to accelerate development in novel & advanced oncology therapies — from the starting line

View All Webinars

OCT Southern California
The Chinese Bioscience Association (CBA) West Annual Conference

View All Events

Phase I study helps company secure second indication for lead product with Healthy volunteer study in Australia
Biotechnology company looking for Oncology CRO services. Regulatory and recruitment expertise expedites clinical trial timelines for Oncology clinical study.
Clinical trial monitoring supports phase III wet AMD trial

View All Case Studies

Rare Disease Clinical Trials: Unveiling Insights and Charting Progress
Unlocking the Future of Healthcare: Exploring Global Clinical Trends in Cell & Gene Therapy
Nasopharyngeal Carcinoma: Unveiling Facts, Statistics, and Clinical Research Developments

View All Faqs

Infectious Diseases – Global Clinical Trial Landscape (2018-2023)
Cell and Gene Therapies Global Clinical Trial Landscape (2018-2022)
Rare Disease – Global Clinical Trial Landscape (2018-2022)

View All Whitepapers

BACK
Medical and Regulatory Consulting
Patient Recruitment and Site Selection
Early Phase Trials in Australia
Clinical Operations and Project Management
Site Management Organization (SMO)
Biometrics and Data Management
Virtual Clinical Trials
Real world data
Laboratory Services
FLEX

BACK
Oncology CRO services
Pharmacometric Services
Drug Development Consulting
GMO Solutions
Liver Disease CRO services
Infectious diseases and Vaccines CRO services
Orphan and rare disease CRO services
Clinical and Regulatory Strategy

BACK

Working at Novotech

Life at Novotech

Career Development

Global Career Opportunities

China Career Opportunities

September 24, 2023 News

Novotech Awarded Cell & Gene Therapy CRO Excellence 2023

Singapore – 19 September 2023 - Novotech, the leading Asia Pacific centred biote

July 12, 2023 News

Novotech Announced as Finalist for Asia Pacific Cell & Gene Therapy CRO Excellence Awards 2023

Singapore - Novotech, the leading Asia Pacific centred biotech CRO with global e

July 10, 2023 News

Novotech Presents Technical Session on Clinical Trial Success Factors at BIOPLUS-INTERPHEX KOREA…

Seoul, Korea - Novotech, the leading Asia Pacific centred biotech CRO with globa

View all news

September 22, 2023 Report

Primary Biliary Cholangitis – Global Clinical Trial Landscape (2023)

Primary biliary cholangitis (PBC) is a chronic liver condition characterized by T-cell lymphocyte-mediated damage to bile ducts, potentially leading to biliary cirrhosis and liver failure if left u

September 1, 2023 Report

Nasopharyngeal Carcinoma: Global Clinical Trial Landscape

Nasopharyngeal carcinoma is the most common cancer originating from the nasopharyngeal epithelium and is often undifferentiated. It is mainly found in Asia and Africa.

View all reports

September 19, 2023 Webinar

Clinical trials in China: unlocking the potential of advanced therapies

Arsalan Arif: Hi, everyone. I'm Arsalan Arif with Endpoints News.

June 21, 2023 Webinar

Endpoints at BIO 2023: Forging new biotech ties with China

John Caroll: Well, good afternoon, good morning, or wherever you may be in the world today

View all webinars

August 28, 2019 Case Study

Phase I study helps company secure second indication for lead product with Healthy volunteer study…

The Background Early clinical-stage US biotech DiaMedica engaged Novotech to provide CRO services and help it take advantage o

View all case studies

September 13, 2023 FAQ

Rare Disease Clinical Trials: Unveiling Insights and Charting Progress

A rare disease, as defined by the WHO, is one that affects fewer than one person in every 1,000 and is typically deadly.

View all faqs

September 19, 2023 Whitepaper

Infectious Diseases – Global Clinical Trial Landscape (2018-2023)

In the twenty-first century, the world has been dealing with large outbreaks of infectious diseases, which have not o

View all whitepapers

Covid-19 Notice important updates

Find content relevant to:

Liver Disease Oncology Hematology Cell and Gene Therapy Immunology Company News Disease Reports Webinars

September 26-27, 2023 Events

OCT Southern California

Hyatt Regency La Jolla at Aventine, San Diego, USA

September 30, 2023 Events

The Chinese Bioscience Association (CBA) West Annual Conference

Crowne Plaza Hotel Foster City, CA

View all events

Medical and Regulatory Consulting

Novotech’s Medical and Regulatory Consulting team offers full range of pre-clinical, regulatory affairs support, medical and pharmacovigilance consulting services.

Learn more
Patient Recruitment and Site Selection

Novotech relies on years of experience, in-country knowledge and real-life big data to identify and propose the best-performing sites for your study.

Learn more
Early Phase Trials in Australia

Australia is a preferred destination for early phase trials because of simple and fast regulatory stream and lucrative R&D cash refund scheme.

Learn more
Clinical Operations and Project Management

Novotech’s streamlined and integrated clinical trial services are delivered by a dedicated team of professionals with deep industry and therapeutic area expertise across all phases of clinical development.

Learn more
Site Management Organization (SMO)

Discover the power of clinical excellence with Acrostar's SMO Division, a dedicated entity operating as part of Novotech.

Learn more
Biometrics and Data Management

Delivering accurate, high-quality and timely biostatistics in clinical trials services, including statistical planning, analysis and reporting.

Learn more
Virtual Clinical Trials

How virtual clinical trials can offer patient retention and cost benefits compared to traditional trials.

Learn more
Real world data

Accelerating patient recruitment and drug development with real world data (RWD)

Learn more
Laboratory Services

Our bioanalytical services assist our customers in every stage of their molecule development.

Learn more
FLEX

Our MISSION is to create career development opportunity for everyone.

Learn more

Oncology CRO services

The landscape of Oncology in Asia-Pacific Biotechnology companies are facing increased challenges around participant recruitment and rete

Learn more
Pharmacometric Services

Our team can assist in all clinical study phases and in study designs ranging from first in human, single ascending dose, multiple ascending dose, drug-drug interaction, bioavailability/bioequivalence, food effect and special population studies.

Learn more
Drug Development Consulting

Novotech Drug Development Consulting is a full-service global product development and strategic regulatory group, providing comprehensive “lab to launch” program development services.

Learn more
GMO Solutions

Novotech initiated the first national, privately owned, commercial Institutional Biosafety Committee (IBC) in Australia, successfully accredited b

Learn more
Liver Disease CRO services

The landscape of Liver diseases in Asia-Pacific Biotechnology companies consider locations in the Asia-Pacific region, s

Learn more
Infectious diseases and Vaccines CRO services

Providing Infectious diseases services and Vaccines CRO services Many biotechnology companies look at the Asia-Pacific region for their t

Learn more
Orphan and rare disease CRO services

Landscape of Rare and Orphan diseases in Asia-Pacific There may be as many as 8,000 rare diseases, affecting between 6% and 8% of the wor

Learn more
Clinical and Regulatory Strategy

Many biotechnology companies come to Australia to conduct early phase clinical trials and take advantage of straightforward regulatory streams and

Learn more

People Culture

Our workplace culture reflects the passion of our people, and we will support you to develop and achieve at all stages of your career and life.

Working at Novotech

Novotech is the leading Asia-Pacific contract research organisation (CRO) providing clinical development services across all clinical trial phases and therapeutic areas and global product development and regulatory affairs consulting through our in-house Novotech Drug Development Consulting team.

Life at Novotech

There are many reasons people love working at Novotech, but when you join it will be our open, inclusive, and flexible work culture that you notice first.

Career Development

We are committed to providing ongoing professional development training, a competitive bonus structure, a supportive work environment, variety in their role, and the opportunity for career development and advancement across all areas of the organisation to our employees.

Global Career Opportunities

We are committed to hiring ambitious and ethical professionals genuinely excited to be a part of the dynamic Life Sciences industry and who relish a challenge.

China Career Opportunities

We are committed to hiring ambitious and ethical professionals genuinely excited to be a part of the dynamic Life Sciences industry and who relish a challenge.

Search Novotech

December 8, 2022

Home / Reports

Peanut Allergy Asia Pacific – Clinical trial landscape

Similar to the west, Australia in the APAC region has the highest rate of peanut allergy affecting around 3% of children.

Other relevant content

February 4, 2020 Report

Accelerating Immunotherapy Clinical Trials in Asia-Pacific

February 20, 2023 Report

Rheumatoid arthritis– Global Clinical trial landscape- Focus on Asia Pacific

October 10, 2022 Report

C3 Glomerulopathy (C3G)

Talk to an expert team member

Receive a timely response to an enquiry about a service, process or technical questions.
Enter your details and the right person at Novotech will get in touch with you soon.

First Name

Last Name

Company Name

Company Email

Job Title

Phone

How can we help?

I agree to the terms of service.

By ticking this box, you consent to us storing and processing your personal data to provide you this content and future content that may be of interest. To withdraw consent or unsubscribe at any time contact communications@novotech-cro.com.

News & Resources
Solutions
Expertise
Careers
About
Contact

© Novotech 2023 - All rights reserved. Privacy Whistle-blower policy Disclaimer NHH Slavery Statement NHH Recruitment Scams - Website Alert Change of Banking Details Scam